MORPHIC THERAPEUTIC Trademark

Trademark Overview

On Wednesday, June 23, 2021, a trademark application was filed for MORPHIC THERAPEUTIC with the United States Patent and Trademark Office. The USPTO has given the MORPHIC THERAPEUTIC trademark a serial number of 90790088. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Wednesday, February 28, 2024. This trademark is owned by Morphic Therapeutic, Inc.. The MORPHIC THERAPEUTIC trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals and pharmaceutical preparations for use in the treatment of autoimmune, cardiovascular and metabolic diseases, as well as fibrosis and cancer
morphic therapeutic

General Information

Serial Number90790088
Word MarkMORPHIC THERAPEUTIC
Filing DateWednesday, June 23, 2021
Status730 - FIRST EXTENSION - GRANTED
Status DateWednesday, February 28, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 21, 2023

Trademark Statements

Goods and ServicesPharmaceuticals and pharmaceutical preparations for use in the treatment of autoimmune, cardiovascular and metabolic diseases, as well as fibrosis and cancer
NOT AVAILABLE"THERAPEUTIC"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, September 8, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameMorphic Therapeutic, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWaltham, MA 02451
Party NameMorphic Therapeutic, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWaltham, MA 02451

Trademark Events

Event DateEvent Description
Saturday, June 26, 2021NEW APPLICATION ENTERED
Wednesday, September 8, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, March 15, 2022ASSIGNED TO EXAMINER
Tuesday, March 15, 2022NON-FINAL ACTION WRITTEN
Tuesday, March 15, 2022NON-FINAL ACTION E-MAILED
Tuesday, March 15, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, September 15, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, September 15, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, September 16, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, November 23, 2022NON-FINAL ACTION WRITTEN
Wednesday, November 23, 2022NON-FINAL ACTION E-MAILED
Wednesday, November 23, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, December 6, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, December 6, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, December 6, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, February 15, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 1, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 21, 2023PUBLISHED FOR OPPOSITION
Tuesday, March 21, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Thursday, April 20, 2023EXTENSION OF TIME TO OPPOSE RECEIVED
Sunday, July 30, 2023EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Tuesday, September 12, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, February 28, 2024SOU EXTENSION 1 FILED
Wednesday, February 28, 2024SOU EXTENSION 1 GRANTED
Wednesday, February 28, 2024SOU TEAS EXTENSION RECEIVED
Thursday, February 29, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 30, 2024TEAS STATEMENT OF USE RECEIVED
Wednesday, August 28, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, August 28, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, August 28, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Wednesday, August 28, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED

Related Keywords

therapeutic morphic diseases well fibrosis cancer metabolic cardiovascular pharmaceutical preparations treatment autoimmune